168 related articles for article (PubMed ID: 32131547)
1. Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription.
Oh SS; Lee KW; Madhi H; Jeong JW; Park S; Kim M; Lee Y; Han HT; Hwangbo C; Yoo J; Kim KD
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131547
[TBL] [Abstract][Full Text] [Related]
2. Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway.
Kim SO; Cha HJ; Park C; Lee H; Hong SH; Jeong SJ; Park SH; Kim GY; Leem SH; Jin CY; Hwang EJ; Choi YH
Biosci Trends; 2019; 13(4):324-333. PubMed ID: 31527329
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway.
Gao Y; Chen DL; Zhou M; Zheng ZS; He MF; Huang S; Liao XZ; Zhang JX
Cell Death Dis; 2020 Oct; 11(10):866. PubMed ID: 33067427
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial-Mesenchymal Transition and Stemness Properties.
Kuan FC; Li JM; Huang YC; Chang SF; Shi CS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139437
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of kazinol A derived from Broussonetia papyrifera on human bladder cancer cells, T24 and T24R2.
Park S; Fudhaili A; Oh SS; Lee KW; Madhi H; Kim DH; Yoo J; Ryu HW; Park KH; Kim KD
Phytomedicine; 2016 Nov; 23(12):1462-1468. PubMed ID: 27765366
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
Ryu H; Jin H; Ho JN; Bae J; Lee E; Lee SE; Lee S
Biol Pharm Bull; 2019; 42(1):66-72. PubMed ID: 30606990
[TBL] [Abstract][Full Text] [Related]
10. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
Lee S; Yoon CY; Byun SS; Lee E; Lee SE
J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells.
Yoon SJ; Park I; Kwak C; Lee E
Oncol Rep; 2003; 10(5):1363-7. PubMed ID: 12883708
[TBL] [Abstract][Full Text] [Related]
12. Involvement of autophagy in cordycepin-induced apoptosis in human prostate carcinoma LNCaP cells.
Lee HH; Kim SO; Kim GY; Moon SK; Kim WJ; Jeong YK; Yoo YH; Choi YH
Environ Toxicol Pharmacol; 2014 Jul; 38(1):239-50. PubMed ID: 24973666
[TBL] [Abstract][Full Text] [Related]
13. The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance.
Liu D; Ke J; Liu Y; Rao H; Tang Z; Liu Y; Zhang Z; You L; Luo X; Sun Z; He Z; Li F; Qiu Z; Hu J; Mbadhi MN; Tang J; Wu F; Li S
Mol Carcinog; 2021 Dec; 60(12):813-825. PubMed ID: 34499772
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.
Kim HJ; Gong MK; Yoon CY; Kang J; Yun M; Cho NH; Rha SY; Choi YD
Yonsei Med J; 2020 Jul; 61(7):587-596. PubMed ID: 32608202
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
Zhou Y; Ling XL
Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345
[TBL] [Abstract][Full Text] [Related]
16. BMI1 activates P-glycoprotein via transcription repression of
Chen MK; Zhou JH; Wang P; Ye YL; Liu Y; Zhou JW; Chen ZJ; Yang JK; Liao DY; Liang ZJ; Xie X; Zhou QZ; Xue KY; Guo WB; Xia M; Bao JM; Yang C; Duan HF; Wang HY; Huang ZP; Qin ZK; Liu CD
Aging (Albany NY); 2021 Jul; 13(14):18310-18330. PubMed ID: 34270461
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells.
Cho SH; Kang IC
Biochem Biophys Res Commun; 2018 Apr; 498(3):431-436. PubMed ID: 29496448
[TBL] [Abstract][Full Text] [Related]
18. MDR1 mediated chemoresistance: BMI1 and TIP60 in action.
Banerjee Mustafi S; Chakraborty PK; Naz S; Dwivedi SK; Street M; Basak R; Yang D; Ding K; Mukherjee P; Bhattacharya R
Biochim Biophys Acta; 2016 Aug; 1859(8):983-93. PubMed ID: 27295567
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species‑mediated mitochondrial death pathway.
Lee HH; Park C; Jeong JW; Kim MJ; Seo MJ; Kang BW; Park JU; Kim GY; Choi BT; Choi YH; Jeong YK
Int J Oncol; 2013 Mar; 42(3):1036-44. PubMed ID: 23292300
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells.
Lee EJ; Kim WJ; Moon SK
Phytother Res; 2010 Dec; 24(12):1755-61. PubMed ID: 20564512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
